MK-0557

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameMK-0557
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuropeptide Y receptor type 5 antagonists
TargetsNeuropeptide Y receptor type 5
Therapy Area/IndicationsSchizophrenia, ParanoidSchizophreniaObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsSchizophrenia, ParanoidSchizophreniaObesity

Other Information

ATC CodeN/A
Related LinksN/A